Interventional treatment of postthrombotic syndrome by unknown
Leitthema
Gefässchirurgie 2016 · [Suppl 2]: 21:S37–S44
DOI 10.1007/s00772-016-0156-4
Published online: 12 July 2016
© The Author(s) 2016 . This article is available
at SpringerLink with Open Access
H. Jalaie1 · K. Schleimer1 · M. E. Barbati1 · A. Gombert1 · J. Grommes1 · M. A. F. de
Wolf2 · R. de Graaf2 · C. H. A. Wittens1,2
1 Klinik für Gefäßchirurgie, Universitätsklinikumder RWTH Aachen, Europäisches Gefäßzentrum Aachen-
Maastricht, Aachen, Germany





The incidence of deep vein thrombosis
(DVT) in western Europe is 1 per 1000
persons/year [39]. Depending on the lo-
cation and extent of DVT 20 –83%of pa-
tients develop postthrombotic syndrome
(PTS)despite optimal anticoagulation [1,
25]. Approximately40%ofDVTsinvolve
the iliofemoral veins [6], the spontaneous
recanalization of which is insuﬃcient in
around 70% of cases [29]. Not only the
incidence but also the morbidity is as-
sociated with a signiﬁcant increase in
PTS following iliofemoral DVT. Up to
50% of patients with iliofemoral DVT
develop severe PTS under conservative
treatment [1]. A study by Kahn et al.
showed that iliofemoral DVT is a major
risk factor for the development of severe
PTS [19]. Venous claudication occurred
within 5 years in 44% of patients with
iliofemoral DVT and venous ulcers in
15% [17, 30]. Due to the high thrombus
load, iliofemoral DVT bears a high risk
of recurrence, which is in turn associated
with a greater risk of PTS [5, 7, 14]. The
symptoms of PTS include pain, cramps,
feeling of heaviness in the legs, paras-
thesia, pruritus and venous claudication.
Symptoms improve in a lying position
and on lifting the aﬀected leg. The fol-
lowing ﬁndings are observed: edema and
increased leg circumference, varices, col-
lateral veins on the abdominal wall or in
the groin region, skin redness, hyper-
pigmentation, skin induration, subcuta-
neous ﬁbrosis and venous ulcers. The oc-
The German version of this article can be found
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currence of PTS signiﬁcantly reduces the
quality of life [21] and has considerable
socioeconomic consequences [18]. A to-
tal of six diﬀerent PTS scoring systems
and classiﬁcations have been established,
which assign a points score to the vari-
ous symptoms and ﬁndings. Depending
on this points score, PTS is classiﬁed
as mild, moderate or severe. The Vil-
lalta score is the most commonly used
system for diagnosis and classiﬁcation
(. Table 1). The Brandjes and Ginsberg
scores are also used only for PTS. The
Widmer score, the CEAP classiﬁcation
(C = clinical condition, E = etiology, A =
anatomical location, P = pathophysiol-
ogy)andthevenousclinical severityscore
(VCSS) are used for the classiﬁcation of
all chronic venous diseases [36].
Pathogenesis
Postthrombotic obstruction involving
increased outﬂow resistance, damaged
venous valves and reﬂux as well as
ﬁbrotic venous walls with reduced com-
pliance cause venous hypertension [8,
13, 28]. The increased venous pressure
is transmitted to the capillaries, which
then dilate and increased capillary per-
meability also occurs. This results in
edema, inﬂammation and pigmentation
due to hemosiderin deposits and, thus,
ultimately to the typical skin changes
and venous ulcerations seen in PTS. Ve-
nous hypertension also causes distension
of the deep veins and increased valve
insuﬃciency, which is also transmitted
to the superﬁcial venous system via the
perforating veins (secondary varicosis)
[12, 16]. According to current knowl-
edge, proximal stenosis or occlusion
contributes more to the development
of venous hypertension and PTS than
reﬂux [19, 20, 33, 35].
Conservative treatment
Compression therapy and anticoagula-
tion form the basis for the conservative
management of PTS. Overall, compres-
sion therapy reduces venous pressure,
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Evaluation result 0–4 no postthrombotic
syndrome (PTS), 5–9 mild PTS, 10–14 mod-
erate PTS, 15–33 severe PTS
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Fig. 18Anatomy of the venous system in the
inguinal region. VFC common femoral vein,VSM
great saphenous vein VF femoral vein,VPF pro-
funda femoris vein
prevents or reduces edema formation
and improves microcirculation. Thus,
compression therapy not only prevents
but also improves PTS ﬁndings [4, 31].
In cases where compression therapy is
contraindicated, such as severe periph-
eral arterial disease (PAD) and periph-
eral neuropathy, intermittent pneumatic
compression therapy represents a rea-
sonable alternative [38].
Surgical treatment
Palma and Esperon ﬁrst described the
surgical treatment of venous obstruction
by means of a femorofemoral venous by-
pass using a saphenous vein crossover
graft in 1959 [27]. Although this ve-
nous bypass achieves high long-term pa-
tency rates, venous obstruction is often
inadequately treated due to the small di-
ameter of the saphenous vein. For this
Fig. 28 Indications depending on the extent of chronic venous obstruction:awithout common
femoral vein involvement andbwith common femoral vein involvement
reason, we favor large caliber, ring-re-
inforced polytetraﬂuoroethylene (PTFE)
grafts with a diameter of 12–14 mm.
Interventional treatment
While PTS signiﬁcantly impairs patient
quality of life, it is very rarely threaten-
ing to life or extremities; therefore, in our
opinion, the objective should be to use as
minimally invasive a treatment approach
as possible. Percutaneous transfemoral
recanalization of the iliac veins using
stent angioplasty has become increas-
ingly more important in recent years,
ever since Neglén et al. ﬁrst published
the technique in 2000 [22]. It is now es-
tablished as a low-risk treatment option
with good long-term results.
Indications
The indications for recanalization in the
presence of PTS need to be made with
great caution. In the authors’ opinion,
interventional treatment is indicated in
the case of signiﬁcant impairment to the
quality of life, particularly due to venous
claudication or non-healing venous ul-
cers. Asymptomatic iliofemoral or ilio-
caval chronic venous obstruction (CVO)
should be conservatively treated. Above
all, complex iliocaval recanalization with
orwithoutendophlebectomyshouldonly
be performed in cases where the patient’s
level of suﬀering is high. Recanalization
at the iliocaval level in the case of insuf-
ﬁcient inﬂow from the periphery due to
postthrombotic stenosis or occlusion of
the femoral vein (FV) and deep femoral
vein (DFV) that extends distally is likely
tobe ineﬀective and therefore contraindi-
cated. Thus, the FV and DFV require
careful preoperative evaluation (. Fig. 1).
In the case of inﬂow obstruction due
to postthrombotic trabeculae in the re-
gion of the common femoral vein (CFV),
endophlebectomy of this vein should be
performed as part of interventional re-
canalization, possibly including creation
of an arteriovenous (AV) ﬁstula in or-
der to ensure suﬃcient inﬂow and pre-
vent early thrombotic occlusion ([40, 15],
. Fig. 2).
Patientsneed tobe explicitly informed
about the procedure, possible complica-
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tions, postoperative adjunctive therapy
(e.g. anticoagulation and compression)
and treatment results.
Diagnostic work-up
Using duplex ultrasound, combined with
magnetic resonance (MR) phlebography
or computed tomography (CT) phlebog-
raphy, the extent of PTS can be visualized
and surgery can be planned. The femoral
and crural veins and venous valves in
particular, as well as the morphology
and function, can be well visualized us-
ing duplex ultrasound; however, MR and
CT phlebography are better suited to the
evaluation of iliocaval circulation. Both
techniques are capable of achieving good
visualization of stenosis, occlusion, atre-
sia, external compression and collaterals.
In patients with PTSwe recommendper-
forminggadolinium-enhancedMRphle-
bography, which additionally visualizes
intraluminal trabeculae and vessel wall
thickening; however, contrast medium
administered forCT phlebography in the
setting of PTS is unable to reach all vein
segments, with the result that not all in-
travenous lesions can be detected and
the extent of ﬁndings may be underesti-
mated [2]. The extent ofCVOneeds to be
diﬀerentiated preoperatively as follows:
1. Iliac or iliocaval CVO,
2. Iliac or iliocaval CVO with CFV
involvement.
This classiﬁcation is relevant for treat-
ment as the former group can be treated
usingapurelyendovascularapproachbut




Irrespective of the location of obstruc-
tion, we perform recanalization with the
patient in the supine position and un-
der general anesthesia. Venous dilatation
and stenting is painful and can take some
time. Performing the procedure with the
patient under local anesthesia should be
reserved only for patients with circum-
scribed stenosis in the iliac region, e. g.
May-Thurner syndrome. The CFV, FV,
popliteal vein (PV), right internal jugu-
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Interventional treatment of postthrombotic syndrome
Abstract
Background. Postthrombotic syndrome (PTS)
is the development of symptoms and signs of
chronic venous insuﬃciency following deep
vein thrombosis (DVT) and has a signiﬁcant
negative eﬀect on the quality of life. The
current understanding is that the clinical
manifestation of PTS is related more to
venous obstruction than it is to venous reﬂux.
The use of interventional techniques for the
treatment of venous obstruction and/or
venous occlusion has rapidly increased in
recent years.
Objective. This article summarizes the
current concept of endovenous and hybrid
interventions and presents the optimized
treatment of choice in patients with chronic
symptomatic venous obstruction.
Methods. We performed a systematic
literature search in the Medline database to
identify relevant studies on the treatment of
patients with PTS.
Results. A meta-analysis of the relevant
studies showed that this minimally invasive
procedure is an eﬀective treatment option
with low morbidity and no mortality. Use of
the newly developed dedicated venous stents
showed promising results with good mid-
term patency rates and a signiﬁcant decrease
in related symptoms.
Conclusion. Interventional therapy for the
treatment of symptomatic chronic venous
obstruction has become themethod of choice
in recent years. More studies are needed
to evaluate the long-term success rate of
dedicated venous stents.
Keywords
Postthrombotic syndrome · Chronic venous
obstruction · Venous recanalization ·
Endophlebectomy · Venous stents
Interventionelle Therapie des postthrombotischen Syndroms
Zusammenfassung
Hintergrund. Das postthrombotische
Syndrom (PTS) als Langzeitfolge der tiefen
Beinvenenthrombose (TVT) kann zu einer
erheblichen Beeinträchtigung der Lebensqua-
lität führen. Nach neuerem Erkenntnisstand
trägt die obstruktive Komponente mehr
zur Entstehung der Symptomatik bei als
die reﬂuxive. Interventionelle Verfahren
zur Beseitigung der venösen Obstrukti-
on/Okklusion haben im letzten Jahrzehnt
rasant an Bedeutung zugenommen.
Zielsetzung. In diesem Beitrag wird die
endovaskuläre bzw. Hybridbehandlung der
symptomatischen chronisch-venösen Ob-
struktion und unser Konzept zur Optimierung
derselben dargestellt.
Methoden. Die elektronische Datenbank
„medline“ wurde systematischnach Artikeln
in deutscher oder englischer Sprache
durchsucht, welche die Behandlung des PTS
thematisieren.
Ergebnisse. Alle zugrundeliegenden Studien
zeigen, dass es sich bei dieser wenig
invasiven Operation um eine eﬀektive
Behandlungsmethode ohne Mortalität mit
wenig Morbidität handelt. Die Oﬀenheits-
raten sind gut. Es lässt sich ein signiﬁkanter
Rückgang der Beschwerden erzielen. Unsere
Kurzzeitergebnisse mit speziellen venösen
Stents sind erfolgversprechend.
Schlussfolgerung. Die interventionelle The-
rapie zur Behandlung der symptomatischen
chronisch-venösen Obstruktion hat sich in
den letzten Jahren zur Therapie der Wahl
entwickelt. Die im Kurzzeitverlauf nachge-
wiesenen Vorteile der speziellen venösen
Stents sollten anhand von kontrollierten
Vergleichsstudien evaluiert werden.
Schlüsselwörter
Postthrombotisches Syndrom · Chronisch-
venöse Obstruktion · Venöse Rekanalisation ·
Endophlebektomie · Venöse Stents







lar vein and contralateral CFV are suit-
able for recanalization access. The great
saphenous vein (GSV) and the DFVmay
be used for access as a last resort. In the
case of CFV involvement, we favor the
ipsilateral FV between the middle and
proximal third as the puncture site. This
enables the tip of the vascular sheath to
be placed in front of the conﬂuence of
the DFV with the FV. In this way, the full
length of theCFVcanbe assessed and the
procedure performed according to the
relevant pathology. Ultrasound-guided
venous puncture is performed. Once
a venous sheath has been introduced us-
ing the Seldinger technique, a variety of
wires and catheters can be used to pass
the stenosis or occlusion. For recanal-
ization, we use a stiﬀ hydrophilic wire
supported by a slightly curved catheter.
The recanalization of segments aﬀected
by postthrombotic changes can take be-
tween minutes and hours, depending on
the extent of lesions. This requires a high
level of patience and precision. Once the
vein segment aﬀected by postthrombotic
changes has been passed, the hydrophilic
wire should be exchanged for amore sta-
ble wire (super-stiﬀ wire). The area of
constriction or occlusion can then be di-
lated using a large lumen balloon. The
vein should be predilated to at least the
diameter of the planned stent. Postdila-
tion is performed following stent place-
ment. Stent-assisted percutaneous trans-
luminal angioplasty (stent PTA) should
be performed from healthy to healthy
segments, i. e. the entire venous seg-
ment aﬀected bypostthrombotic changes
should be repaired by stent PTA. Com-
mon iliac vein (CIV) constriction should
always be stented over. At the same time,
overly wide placement of the stent in the
CIV should be avoided. Control phle-
bography in two planes is mandatory.
Following successful recanalization, vig-
orous contrast medium outﬂow occurs
along the stented iliac ﬂow path. Collat-
erals should no longer be detectable ([9,





In the absence of suﬃcient inﬂow, early
thrombotic occlusion is virtually un-
avoidable despite successful iliac stent
PTA. The inﬂow is supplied primarily
with venous blood from the FV, the
DFV and the GSV. Even in the case of
postthrombotic FV occlusion, collateral
inﬂow via the DFV may be adequate. In
the case of CFV involvement and hence
also signiﬁcantly impaired peripheral
inﬂow, surgery should be performed
as a hybrid procedure. The CFV is
visualized and, following longitudinal
venotomy, postthrombotic trabeculae
are excised (. Fig. 4). Patch angioplasty
is then performed using bovine patch
material and in addition, an AV ﬁstula
is created between the common femoral
artery and CFV using a ring-reinforced
6 mm PTFE graft in a loop conﬁgura-
tion. Once peripheral venous inﬂow is
ensured, stent PTA of the recanalized
iliac or iliocaval vein segment is per-
formed ([40, 15, 32]; . Fig. 5). As, here
again, the basic principle is that the stent
should terminate both proximally and
distally in healthy vein segments, stent
PTA up to the endophlebectomized CFV
is necessary, i. e. the stent terminates, in
contrast to recommendations in arterial
PTA and stent placement, below the
inguinal ligament.
New venous stents
Initially, the same stents as those used in
arterial stent PTA (e. g. Wallstents and
nitinol stents) were used for recanaliza-
tion of the iliac venous circulation. Stent
PTA of a vein aﬀected by postthrom-
botic changes, intraluminal scarring and
often also external compression cannot
be compared with arterial stent PTA for
arteriosclerosis; therefore, the stentsused
for venous recanalization have special re-
quirements:
1 Vein diameter is greater than the
diameter of the corresponding ar-
teries. Stents with a diameter of
12–18 mm are used for venous iliac
recanalization.
2 Postthrombotic lesions are generally
extensive in length, making longer
stents necessary. The deployment
of several overlapping stents is
inadequate to solve this problem, as
this reduces the required ﬂexibility.
3 Postthrombotic veins often show
long segment scarring, in addition
to which external pressure may be
present, e. g. as in May-Thurner
syndrome; therefore, stents with high
radial strength are required.
4 In the case of venous recanalization,
highly ﬂexible stents that adapt to
the anatomical course of the vein
also during movement are required.
The greatest angulation (up to 90°)
while seated is seen particularly in the
region of the iliac bifurcation, where
the external iliac vein (EIV) crosses
into the CIV (. Fig. 6).
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Fig. 49 Intraoperative
site of common femoral
vein endophlebectomy




ing excision of postthrom-
botic trabeculae
Fig. 58 Following recanalization of the pelvic
vessels with endophlebectomy of the common
femoral vein andpatch angioplasty and place-
ment of a loop-shaped arteriovenous ﬁstula
(ringed 6mmPTFE)
This resulted in the development of spe-
cial venous stents, such as the Veniti
Vici (Veniti, St. Louis, MO), Zilver Vena
(Cook, Bloomington, IN) and the sinus
venous stent (OptiMed, Ettlingen, Ger-
many). These dedicated venous stents
combine high ﬂexibility and strong ra-
dial force ([41]; . Fig. 7).
Anticoagulation
Following recanalization, coagulation is
increased due to the intimal lesion re-
sulting from endophlebectomy and stent
placement. Furthermore, hematoma for-
mation with compression of the revas-
cularized vein segment as well as patient
immobilization all play a role. The most
Fig. 68 Follow-up (lateral pelvic X-ray) follow-
ingstentplacement. Maximumﬂexibilityofave-
nous stent in the iliac bifurcation region
common postoperative complication is
occlusion of the recanalized segment due
to thrombosis. Thus, adequate perioper-
ative and postoperative therapeutic anti-
coagulationarecrucial. Therapeuticanti-
coagulation is not paused preoperatively
and 5000 IU heparin is administered in-
traoperatively. Surgery is performed un-
der regular monitoring of the activated
clotting time (ACT), which should be
≥200 s. Therapeutic anticoagulation is
continued postoperatively. When using
vitamin K antagonists for anticoagula-
tion, the target International Normal-
izedRatio (INR) range should be 2.5–3.5.
If values fall below the lower limit, we
recommend additionally administering
low-molecular heparin in a therapeutic
dose. New oral anticoagulants (NOAC)
are coming increasingly into use. At our
clinic, therapeuticanticoagulationiscon-
tinued for at least 6 months postoper-
atively. Anticoagulation should be ad-
justed thereafter to the patient’s individ-
ual risk of thrombosis recurrence [15].
Postoperative adjunctive
therapy
Early mobilization is crucial to the suc-
cess of interventional therapy. If this
cannot be achieved, intermittent pneu-
matic compression therapy should be
initiated. The wearing of compression
stockings should be continued for at
least 1 year postoperatively. A duplex ul-
trasound examination prior to discharge
is recommended. We perform the ﬁrst
patient follow-up on the 14th postoper-
ative day. Should thrombotic occlusion
be detectable at that time, this can be
adequately treated with local lysis. If
stent-related complications are detected,
these can be resolved following lysis via
the same access.
Current results using venous
stents
Between March 2012 and July 2014, we
performed venous recanalization using
sinus-Venous stents in 40 patients with
PTS (excluding patients with compres-
sion syndrome and no PTS) at one of
our centers. . Table 2 shows the demo-
graphic data of patients. Mean follow-
up time was 5.5 months (range 1–18
months). There were no mortalities.
The primary patency rate after 3, 6 and
12 months was 97%, 93% and 85%,
respectively. Rethrombosis was seen
in three patients, which could be suc-
cessfully treated using an endovascular
approach. Stent-related complications
are shown in . Table 3. Therapeutic an-
ticoagulation caused minor bleeding not
Gefässchirurgie Suppl 2 · 2016 S41
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Fig. 79 In vitro
demonstration
of a venous stent.
a, bVici Venous
Stent® (Veniti, St.




requiring treatment in ﬁve patients over-
all. The mean Villalta score decreased
postoperatively from 11.5 (range 2–24)
to 5.0 (range 0–16) [41].
Discussion
Although PTS signiﬁcantly impairs the
quality of life, it rarely poses a threat
to life or extremities. The goal of treat-
ment is to alleviate symptoms and im-
prove the quality of life. In our opinion
this should be achievedwith an approach
that is as minimally invasive as possible.
In 2000, Neglén et al. described the tech-
nique of interventional recanalization of
the iliofemoral venous circulation [22]
and published the largest study to date
on the technique in 2006 (n = 982 pa-
tients and 464 with PTS).They primarily
used Wallstents and, in a small number
of cases, nitinol stents developed for the
arterial system. Mortality was 0%, while
the primary patency rate was 57% in
PTS patients after 72months and the sec-
ondary patency rate was 86%. Neglén et
al. demonstrated a signiﬁcant improve-
ment in the quality of life in patients [23].
Hartung et al. published a study with 89
patients including 35 who suﬀered from
PTS and performed stent PTAusing only
Wallstents. No cases of pulmonary em-
bolism or mortality were observed pe-
rioperatively. The primary patency rates
after12months, 3 years and10yearswere
89%, 83% and 83%, respectively [11].
Blättler and Blättler [3], Raju et al. [34]
and te Riele et al. published intermediate
results (follow-up 9–15months) showing
primary patency rates of 58–79% [37].
Compared with these intermediate re-
sults, our results using new venous stents
are promising.
It is diﬃcult to directly compare the
available studies due to their inhomoge-
neous patient populations. The major-
ity of studies mainly report about com-
pression symdrome (e. g. May Thurner
Syndrome), in which signiﬁcantly bet-
ter patency rates are achieved. A variety
of stents were used, observational peri-
odsoftenvaried signiﬁcantly andwhile in
some studies only interventional recanal-
izationwasperformed, inothers complex
hybridprocedureswereperformed[3, 11,
23, 24, 34, 37].
Interventional recanalization for
venous femoro-iliocaval obstruction/
occlusion has proven to be a minimally
invasive, safe and eﬀective procedure.
Convincing results are achieved with
low morbidity, good patency rates, a sig-
niﬁcant reduction of symptoms and no
mortality. We observed no symptom
progression in the case of treatment
failure and the option still remains to
perform an open procedure.
Conclusion
Interventional venous recanalization is
becoming increasingly more popular for
the treatment of PTS. In order to ensure
adequate results, the following aspects
need to be taken into consideration:
1 Adequate inﬂow and optimal outﬂow
in the stented vein segment are essen-
tial. This is achieved by performing
stent PTA from healthy to healthy
segments, early mobilization and
compression therapy. Involvement of
the CVF may necessitate endophle-
bectomy as well as creation of an
AV ﬁstula.
2 Only dedicated venous stents should
be used.
3 Adequate perioperative and postop-
erative therapeutic anticoagulation is
mandatory.
4 We recommend close follow-up.
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Mean age (years) 45 (17–68)
Isolated DVT 28 (70)
Recurrent DVT 7 (18)
Asymptomatic DVTa 5 (13)
Time interval between DVT
and treatment (years, range)
6 (1–37)
Left-sided DVT 29 (83)
Right-sided DVT 5 (14)
Bilateral DVT 1 (3)
Moderate Villalta score 11.5 (2–24)
Venous claudication 25 (63)
Superﬁcial venous reﬂux 33 (83)
Deep venous reﬂux 12 (30)
Perforating vein reﬂux 5 (13)
DVT deep vein thrombosis, PTS postthrom-
botic syndrome, CVO chronic venous ob-
struction
aAsymptomatic DVT: no history of DVT but
clear symptoms/findings of PTS with CVO
Taking these premises into account, ve-
nous recanalization is an elegant and safe
procedure associatedwith lowmorbidity
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Readmission due to stent-re-
lated pain
1 (2.5)
Persistent stent compression 2 (5)
Stent tapering 2 (5)
Stent stenosis 2 (5)
Insuﬃcient stenting of the
area of compression
2 (5)
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